- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01878994
Evaluation of a Family Intervention Program for the Management of Overweight or Obese Children (NEREU)
Evaluation of Family Intervention Program for the Treatment of Overweight or Obese Children (Nereu Program): Randomized Clinical Trial
Objectives: To evaluate the effectiveness of the Nereu program compared to standard care (advice on increased physical activity and nutrition) such as a health intervention tool for the childhood obesity management
Methods/Design: The study design is a randomized controlled multicenter clinical trial using two types of treatment. Population and sample: Children 6 to 12 years with overweight or obesity, according to the z score of body mass index (BMI z) >= 1 for age and gender defined by International Obesity Task Force (IOTF). It is considered necessary to recruit 100 children: 50 control group (CG) and 50 Intervention (IG). Study Intervention: Nereu Group: 8 month intervention with 3 weekly training sessions doing physical exercise for children and a weekly session for parents of physical activity and healthy eating habits and behaviour strategies, that involves both parental and child participation. The control group will receive a monthly session of healthy physical and eating habits. Main Outcome Measures: Improvement of BMI z, physical activity and nutrition habits, behaviour components and quality life related to health at the end, 6 and 12 months after intervention.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Forventet)
Fase
- Fase 4
Kontakter og plasseringer
Studiesteder
-
-
-
Lleida, Spania, 25001
- Rekruttering
- USR- Lleida. Atenció primaria. IDIAP Jordi Gol
-
Ta kontakt med:
- Conxita Teixidó, Dra
- E-post: cteixido.lleida.ics@gencat.cat
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Children aged between 6 to 12 years old
- Overweight or obese according to the IOTF criteria
Exclusion Criteria:
- Medical co-morbidities: Diabetes mellitus or hypercholesterolemia or cardiovascular disease that could be contraindicate the sport practice.
- Use of medication that might have an effect on weight loss.
- previous enrolment in another similar treatment program based on reducing obesity.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Placebo komparator: Counselling Group
Each family will receive a single monthly meeting, a total of 8 with 10 minutes duration each one.
The sessions will take place in the consultation of the paediatrician and it will be delivered by the child's nurse or/and paediatrician.
The sessions' contents are about promotion of healthy eating and physical activity habits.
|
|
|
Eksperimentell: Nereu Group
The Nereu treatment program is an intensive family-based behavioural multi-component lifestyle intervention.
Consist in an intensive treatment of 8 months duration (from October to May, that is, an academic year).
The intervention is a multidisciplinary intervention consisting in 4 structured components: (a) physical activity training for children, (b) family theoretical and practical sessions for parents, (c) behaviour strategies, that involves both parental and child participation (d) weekend extra activities.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from Baseline in Body mass index z score (BMIz)
Tidsramme: 4 times: at baseline, at the end of the intervention (8 months later of the baseline), 6 and 12 months post intervention
|
Weight is measured to the nearest of 0.1 kg using an electronic scale and height (Ht) to the nearest of 0.1 cm with a stadiometer, in lightly dressed and without shoes.
The BMIz is calculated according z score of BMI adjusted by age and gender (IOTF).
|
4 times: at baseline, at the end of the intervention (8 months later of the baseline), 6 and 12 months post intervention
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from baseline in Physical activity habits
Tidsramme: 4 times: at baseline, at the end of the intervention (8 months later of the baseline), 6 and 12 months post intervention
|
To measure physical activity will be used an Actigraph accelerometers (GT3X+ models), it will be wear by participants during all day for seven consecutive days.
|
4 times: at baseline, at the end of the intervention (8 months later of the baseline), 6 and 12 months post intervention
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Noemí Serra, INEFC-LLEIDA, University of Lleida
- Hovedetterforsker: Concepció Teixidó, Institut Català de la Salut - Atenció primaria - Lleida
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Serra-Paya N, Ensenyat A, Castro-Vinuales I, Real J, Sinfreu-Bergues X, Zapata A, Mur JM, Galindo-Ortego G, Sole-Mir E, Teixido C. Effectiveness of a Multi-Component Intervention for Overweight and Obese Children (Nereu Program): A Randomized Controlled Trial. PLoS One. 2015 Dec 14;10(12):e0144502. doi: 10.1371/journal.pone.0144502. eCollection 2015.
- Serra-Paya N, Ensenyat A, Real J, Castro-Vinuales I, Zapata A, Galindo G, Sole-Mir E, Bosch-Munoz J, Mur JM, Teixido C. Evaluation of a family intervention programme for the treatment of overweight and obese children (Nereu Programme): a randomized clinical trial study protocol. BMC Public Health. 2013 Oct 23;13:1000. doi: 10.1186/1471-2458-13-1000.
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- PI12/02220
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .